Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Taylor

Showing results (31-40 of 246) with videos related to

Pageof 25
Sort By:
Mediterranean Journal of Rheumatology|July 18, 2020
Pain in Rheumatoid Arthritis: Could JAK Inhibition be the Answer?Puja Mehta, Peter C Taylor
The Lancet. Rheumatology|January 17, 2024
Treating to target or treating the patient in rheumatoid arthritis?Peter C Taylor, Janet Pope
Materials (Basel, Switzerland)|September 13, 2025
Chemical Interactions of Deicing Salts with Concrete Pastes Containing Slag CementMohsen Torabi, Peter C Taylor
Best Practice & Research. Clinical Rheumatology|February 1, 2020
When the first visit to the rheumatologist is established rheumatoid arthritisPeter C Taylor, Shing T Law
Pathology|May 2, 2016
Actinotignum (formerly Actinobaculum) schaalii: a review of MALDI-TOF for identification of clinical isolates, and a proposed method for presumptive phenotypic identificationRobert P Stevens, Peter C Taylor
Mediterranean Journal of Rheumatology|June 12, 2020
SB4 in the Era of Biosimilars: Clinical Data and Real-World ExperienceShing T Law, Peter C Taylor
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Combination cytokine blockade: the way forward in therapy for rheumatoid arthritis?Peter C Taylor, Richard O Williams
Pharmacological Research|October 21, 2019
Role of biological agents in treatment of rheumatoid arthritisShing T Law, Peter C Taylor
Rheumatology (Oxford, England)|June 10, 2019
Rheumatoid arthritis and the emergence of immuno-autonomicsPeter C Taylor, Andrew J Holman
Nature Clinical Practice. Rheumatology|January 18, 2007
Etanercept plus sulfasalazine: added value in rheumatoid arthritis?Benjamin A C Fisher, Peter C Taylor
Pageof 25

Showing results (31-40 of 246) with videos related to

Sort By:
Pageof 25
Mediterranean Journal of Rheumatology|July 18, 2020
Pain in Rheumatoid Arthritis: Could JAK Inhibition be the Answer?Puja Mehta, Peter C Taylor
The Lancet. Rheumatology|January 17, 2024
Treating to target or treating the patient in rheumatoid arthritis?Peter C Taylor, Janet Pope
Materials (Basel, Switzerland)|September 13, 2025
Chemical Interactions of Deicing Salts with Concrete Pastes Containing Slag CementMohsen Torabi, Peter C Taylor
Best Practice & Research. Clinical Rheumatology|February 1, 2020
When the first visit to the rheumatologist is established rheumatoid arthritisPeter C Taylor, Shing T Law
Pathology|May 2, 2016
Actinotignum (formerly Actinobaculum) schaalii: a review of MALDI-TOF for identification of clinical isolates, and a proposed method for presumptive phenotypic identificationRobert P Stevens, Peter C Taylor
Mediterranean Journal of Rheumatology|June 12, 2020
SB4 in the Era of Biosimilars: Clinical Data and Real-World ExperienceShing T Law, Peter C Taylor
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Combination cytokine blockade: the way forward in therapy for rheumatoid arthritis?Peter C Taylor, Richard O Williams
Pharmacological Research|October 21, 2019
Role of biological agents in treatment of rheumatoid arthritisShing T Law, Peter C Taylor
Rheumatology (Oxford, England)|June 10, 2019
Rheumatoid arthritis and the emergence of immuno-autonomicsPeter C Taylor, Andrew J Holman
Nature Clinical Practice. Rheumatology|January 18, 2007
Etanercept plus sulfasalazine: added value in rheumatoid arthritis?Benjamin A C Fisher, Peter C Taylor
Pageof 25